A Phase II, Randomized, Open-Labeled Study to Evaluate Low-Dose Pembrolizumab in Addition to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC) Adhip Arora , V. Seenu , Rajinder Parshad , V. K. Bansal , Anita Dhar , Sandeep Mathur , Pranay Tanwar , Piyush Mishra , Kamal Kataria , Suhani , Ajay Gogia , Brijesh Kumar , K. P. Haresh , Supriya Mallick , Surendra Kumar Saini , Ashutosh Mishra , Babul Bansal , Jyoti Sharma , Jyoutishman Saikia , Krithika Rangarajan , Ekta Dhamija , Chandra Prakash Prasad , Shamim Ahmed Shamin , Sourabh Agastm , Kaushal Kalra , Divvay Vishvam , Kalaivani Mani , Akash Kumar , Sameer Bakhshi , Atul Batra Trials（2025）
关键词
Triple negative, Breast cancer, Immunotherapy, Low dose, Pembrolizumab, Non-metastatic
AI 理解论文
溯源树
样例
